ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 237 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $799,000 | -19.5% | 11 | 0.0% | 0.00% | – |
| Q3 2021 | $992,000 | +3.0% | 11 | 0.0% | 0.00% | – |
| Q2 2021 | $963,000 | -23.1% | 11 | 0.0% | 0.00% | – |
| Q1 2021 | $1,252,000 | -17.8% | 11 | 0.0% | 0.00% | – |
| Q4 2020 | $1,523,000 | +68.5% | 11 | 0.0% | 0.00% | – |
| Q3 2020 | $904,000 | +5.1% | 11 | 0.0% | 0.00% | – |
| Q2 2020 | $860,000 | +75.9% | 11 | 0.0% | 0.00% | – |
| Q1 2020 | $489,000 | -27.1% | 11 | 0.0% | 0.00% | – |
| Q4 2019 | $671,000 | +42.8% | 11 | 0.0% | 0.00% | – |
| Q3 2019 | $470,000 | -32.7% | 11 | 0.0% | 0.00% | – |
| Q2 2019 | $698,000 | -99.4% | 11 | -99.3% | 0.00% | -100.0% |
| Q1 2019 | $111,002,000 | +212.2% | 1,601 | +95.7% | 0.02% | +266.7% |
| Q4 2018 | $35,556,000 | – | 818 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |